Legalization of THC Sales in Alexander City Council

Dec.13.2022

THC, derived from marijuana, can treat or prevent nausea and vomiting caused by cancer drugs. It was legalized statewide unexpectedly.

THC, which is derived from marijuana and can be used to treat or prevent nausea and vomiting caused by cancer medications, was unexpectedly legalized statewide by the State Council on July 1st.

Five companies in Alexandria Port have applied for a license to sell products containing tetrahydrocannabinol (THC), a compound that can cause marijuana to produce a state of excitement.

On Monday, December 12th, the Alexander City Council approved a submission from Ebacco after receiving additional information during a public hearing. However, approval for other applications was delayed due to incomplete submissions.

The THC licensing process is new, having only been approved by the council a few months ago.

THC, which is derived from cannabis, can be used to treat or prevent nausea and vomiting caused by cancer drugs. Surprisingly, the state legislature legalized it statewide on July 1.

This has led city leaders throughout the state to race to find answers on how to regulate the sale of THC through zoning and permits. In October, Alexandria passed a 16-page ordinance that regulates the sale and manufacture of THC-infused edibles, such as gummy bears.

This regulation mandates a license annual fee of $500 and an initial application investigation fee of $500.

Five companies have applied for licenses, including Ebacco located at 410 30th Ave. East, two locations of King Tobacco at 4617 Highway 29 South and 307 N. Nokomis St, Brothers Market at 610 McKay Ave., and Speedway gas station at 1422 Broadway.

#THC products #THC e-cigarettes

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review

Altria on December 19 confirmed that six on! PLUS nicotine pouch products had received U.S. FDA marketing authorization, ending a PMTA review lasting more than a year after the company moved ahead with launch plans before clearance.

Regulations

Dec.20

Product | ELFBAR Launches New Open-System Device in UK with Three Pod Options and 2800mAh Battery

ELFBAR has launched its new open-system device ELFX MEGA, compatible with 2 mL, 5 mL and 10 mL pods and equipped with a 2800mAh battery that delivers significantly longer runtime than its predecessor. The device has passed MHRA notification in the UK and is now available online in the UK at a retail price of around £18.99.

Nov.25 by 2FIRSTS.ai

Study: TikTok Content Frames Nicotine Pouches as “Trendy Accessories,” Diluting Risk Perception Among Youth

A study published in JMIR Formative Research analyzed 132 TikTok videos related to nicotine pouches and found that platform content predominantly presents these products as a “youthful trend” rather than as smoking cessation tools. Health risks are underrepresented, the user base appears largely male, and this portrayal may influence how adolescents perceive the risks associated with nicotine products.

Dec.04 by 2FIRSTS.ai

EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia

The EUIPO has ruled that Imiracle failed to demonstrate actual commercial use of its “Elfbar Crystal” brand in Slovakia, and therefore rejected in full the company’s opposition to Shenzhen SKE Technology’s application to register the “Crystal” trademark. The EUIPO noted that the sales records submitted by Imiracle were limited in scope and that the product packaging was in Ukrainian, which it found insufficient to prove that the products had been placed on the Slovak market.